Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022

Rhea-AI Summary

Concert Pharmaceuticals (NASDAQ: CNCE) will announce its second quarter 2022 financial results on August 4, 2022, before the U.S. markets open. The company will hold a conference call at 8:30 a.m. ET to discuss these results and provide a business update. A new registration system is in place for participants who wish to ask questions. The live call can be accessed by registering here, while an audio-only webcast will be available on the company website for three months.

New Online Registration Required for Live Call to Ask Questions

Audio-Only Webcast Still Available on Concert’s Website

LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the second quarter of 2022, on Thursday, August 4, 2022, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss its second quarter 2022 financial results and provide a business update.

Please note that there is a new system to access the live call in order to ask questions. To join the live call, please register here. A dial in and unique PIN will be provided to join the call.

An audio-only webcast of the call may be accessed in the Investors section of the Company’s website at www.concertpharma.com. A replay of the webcast will be available on Concert’s website for three months.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform^® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220729005197/en/

For additional information contact:

Justine Koenigsberg

(781) 674-5284

ir@concertpharma.com

Source: Concert Pharmaceuticals, Inc.

FAQ

When will Concert Pharmaceuticals report its second quarter 2022 results?

Concert Pharmaceuticals will report its second quarter 2022 financial results on August 4, 2022.

What time is the conference call for Concert Pharmaceuticals' Q2 2022 results?

The conference call will take place at 8:30 a.m. ET.

How can I ask questions during the Concert Pharmaceuticals conference call?

To ask questions during the conference call, participants need to register through a new system.

Where can I access the audio-only webcast of the Concert Pharmaceuticals call?

The audio-only webcast will be available on the Investors section of Concert Pharmaceuticals' website.

How long will the replay of the Concert Pharmaceuticals webcast be available?

The replay of the webcast will be available on Concert's website for three months after the event.